Virtus Investment Advisers, Inc. Aurinia Pharmaceuticals Inc. Transaction History
Virtus Investment Advisers, Inc.
- $286 Million
- Q2 2025
A detailed history of Virtus Investment Advisers, Inc. transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Virtus Investment Advisers, Inc. holds 53,997 shares of AUPH stock, worth $639,324. This represents 0.16% of its overall portfolio holdings.
Number of Shares
53,997
Previous 37,051
45.74%
Holding current value
$639,324
Previous $297,000
53.87%
% of portfolio
0.16%
Previous 0.1%
Shares
3 transactions
Others Institutions Holding AUPH
# of Institutions
248Shares Held
62.5MCall Options Held
1.03MPut Options Held
666K-
Tang Capital Management LLC San Diego, CA10MShares$119 Million5.09% of portfolio
-
Black Rock Inc. New York, NY9.27MShares$110 Million0.0% of portfolio
-
Nea Management Company, LLC Timonium, MD3.97MShares$47 Million2.79% of portfolio
-
State Street Corp Boston, MA2.8MShares$33.1 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.4MShares$28.4 Million0.0% of portfolio
About Aurinia Pharmaceuticals Inc.
- Ticker AUPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,892,000
- Market Cap $1.68B
- Description
- Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...